License to Abbott Sample Clauses

License to Abbott. Institution and Investigator agree that, if either publishes the results of a Study, Abbott is hereby granted an irrevocable, royalty-free license to make and distribute copies of any such publication under any copyright privileges that the Institution and Investigator may have, if any. Abbott shall have the right to independently publish the results of the Study.
Sample 1
License to Abbott. 2.01 BSI hereby grants to ABBOTT a worldwide, exclusive license, with the right to grant sublicenses with BSI's prior written approval, under PROPRIETARY RIGHTS to make, have made, use and sell LICENSED PRODUCTS for DIAGNOSTIC APPLICATIONS. Such exclusive license, with respect to patents included within PROPRIETARY RIGHTS, shall continue until the expiration of the last to expire of such patents, and with respect to unpatented aspects of PROPRIETARY RIGHTS, shall be perpetual. 2.02 ABBOTT shall inform BSI in advance of XXXXXX'x desire to grant sublicenses hereunder, the identity of the proposed sublicensee and the terms of the proposed sublicense. BSI approval of such proposed sublicenses shall NOT be unreasonably withheld. 2.03 If, within four (4) years following May 30, 1989, ABBOTT or an ABBOTT sublicensee have not, in each field of DIAGNOSTIC APPLICATIONS, either (a) submitted an application for governmental regulatory approval required for the sale of a LICENSED PRODUCT, or (b) made a FIRST COMMERCIAL SALE of a LICENSED PRODUCT which does not require governmental regulatory approval, BSI shall, after the expiration of said four (4) year period, have the option to convert XXXXXX'x exclusive license under Paragraph 2.01 to a non-exclusive license for each field of DIAGNOSTIC APPLICATIONS in which neither (a) nor (b) above has occurred, provided that BSI provides ABBOTT with ninety (90) days written notice prior to exercise of such option for each such field. After such four (4) year period has expired, for each field of DIAGNOSTIC APPLICATIONS in which ABBOTT or a sublicensee has performed either (a) or (b) above, prior to notification by BSI to ABBOTT that BSI is exercising the option under this Paragraph 2.03, BSI's option shall terminate.
Sample 1
License to Abbott. DexCom, on behalf of itself and its Affiliates, hereby grants to ADC and its Affiliates (excepting any After-Acquired Affiliates), a nonexclusive, irrevocable, perpetual, non-transferable (except as authorized in Article VIII), worldwide, fully paid-up and royalty-free license, with no right to sublicense, under the Licensed Patents, to make, have made, use, have used, sell, have sold, offer to sell, have offered for sale, import, have imported, store or keep (or have stored or have kept) for those purposes, and otherwise transfer, have transferred, dispose of, or have disposed of, Covered Products.
Sample 1
License to Abbott. For a period of four (4) years following the Effective Date of this Second Amendment, BSI shall not have the option to convert Xxxxxx'x exclusive license under Paragraph 2.01 of the Amended License to a non-exclusive license for the fields of Veterinary Diagnostics, Food/Agricultural Diagnostics and Environmental Diagnostics. Thereafter, BSI shall have such option under the same terms and conditions set forth in Paragraph 2.03 of the Amended License.
Sample 1
License to Abbott. Sutura hereby grants to Abbott a nonexclusive, paid-up, worldwide license under the Sutura Patents to make, have made, use, market, offer for sale, sell and have-sold, devices in the Field Of Use. The rights granted under this License do not include the right to grant sublicenses.
Sample 1

Related to License to Abbott

  • License; Use Upon delivery to an Authorized Person or a person reasonably believed by Custodian to be an Authorized Person of the Fund of software enabling the Fund to obtain access to the System (the “Software”), Custodian grants to the Fund a personal, nontransferable and nonexclusive license to use the Software solely for the purpose of transmitting Written Instructions, receiving reports, making inquiries or otherwise communicating with Custodian in connection with the Account(s). The Fund shall use the Software solely for its own internal and proper business purposes and not in the operation of a service bureau. Except as set forth herein, no license or right of any kind is granted to the Fund with respect to the Software. The Fund acknowledges that Custodian and its suppliers retain and have title and exclusive proprietary rights to the Software, including any trade secrets or other ideas, concepts, know-how, methodologies, or information incorporated therein and the exclusive rights to any copyrights, trademarks and patents (including registrations and applications for registration of either), or other statutory or legal protections available in respect thereof. The Fund further acknowledges that all or a part of the Software may be copyrighted or trademarked (or a registration or claim made therefor) by Custodian or its suppliers. The Fund shall not take any action with respect tot the Software inconsistent with the foregoing acknowledgement, nor shall the Fund attempt to decompile, reverse engineer or modify the Software. The Fund may not xxx, sell, lease or provide, directly or indirectly, any of the Software of any portion thereof to any other person or entity without Custodian’s prior written consent. The Fund may not remove any statutory copyright notice or other notice included in the Software or on any media containing the Software. The Fund shall reproduce any such notice on any reproduction of the Software and shall add any statutory copyright notice or other notice to the Software or media upon Custodian’s request.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.